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Pregnancy success and life-long health depend on a cooperative
interaction between the mother and the fetus in the allocation of
resources. As the site of materno-fetal nutrient transfer, the pla-
centa is central to this interplay; however, the relative importance
of the maternal versus fetal genotypes in modifying the allocation
of resources to the fetus is unknown. Using genetic inactivation
of the growth and metabolism regulator, Pik3ca (encoding PIK3CA
also known as p110α, α/+) we examined the interplay between the
maternal genome and the fetal genome on placental phenotype in
litters of mixed genotype generated through reciprocal crosses of
wildtype and α/+ mice. We demonstrate that placental growth and
structure were impaired and associated with reduced growth of
α/+ fetuses. Despite its defective development, the α/+ placenta
adapted functionally to increase the supply of maternal glucose
and amino acid to the fetus. The speciﬁc nature of these changes
however, depended on whether the mother was α/+ or wildtype
and were related to alterations in endocrine and metabolic proﬁle
induced bymaternal p110α deﬁciency. Our ﬁndings thus show that
the maternal genotype and environment programmes placental
growth and function and identify the placenta as critical in in-
tegrating both intrinsic and extrinsic signals governing materno-
fetal resource allocation.
resource allocation j fetus j placenta j PI3K j nutrient transport
The successful outcome of mammalian pregnancy de-
pends on balancing resource allocation between the genetically-
determined fetal drive for growth and the maternal nutrient re-
quirements to support pregnancy and lactation. Failure to achieve
the right balance can lead to pregnancy complications and abnor-
mal fetal development with long-term consequences for maternal
and offspring health (1, 2). As the interface between the mother
and fetus, the placenta is central to this tug-of-war over nutrient
allocation. Genetic and dietary manipulations during pregnancy
as well as reciprocal crosses between breeds of different sizes
indicate that the placenta can adapt dynamically to both fetal
signals of nutrient demand and maternal signals of nutrient avail-
ability to ensure appropriate allocation of available resources (3-
9). The fetus andmother therefore, have to cooperate to optimise
both offspring and maternal fitness but, to date, little is known
about the relative importance of fetal versus maternal genomes
in balancing resource allocation at the placental level.
The phosphoinositol 3-kinase (PI3K) pathway is highly con-
served and evolved to regulate growth in relation to nutrient
supply (10). In adult tissues, the PI3K p110α isoform is primarily
responsible for mediating the metabolic effects of insulin and
insulin-like growth factors (IGFs); which aremajor feto-placental
growth factors (11-14). Altered placental PI3K signalling, particu-
larly downstream of p110α accompanies adaptations in placental
phenotype when mismatches occur between maternal resource
availability and the fetal genetic drive for growth during mouse
development (15-18). These findings suggest that p110α may be
a critical sensor integrating the various signals involved in pla-
cental adaptation. In mice, inactivating p110α kinase genetically
causes embryonic lethality of p110αD933A/D933A (α/α) homozygotes
(13). In contrast, heterozygotes (p110αD933A/+, α/+) are viable
although growth restricted near term (13, 19). However, nothing
is known about the placenta in these α/+ mutants. Postnatally,
α/+ mice remain lighter and are insulin resistant, glucose intol-
erant and obese, but not overtly diabetic, as adults (13). During
pregnancy the consequences of these metabolic and endocrine al-
terations for placental phenotype and materno-fetal resource al-
location remain unknown. Therefore, this study sought to answer
the following three questions; 1) what role does feto-placental
p110α inactivation have in determining placental phenotype and
resource allocation to fetal growth? 2) what effect does maternal
α/+ phenotype have on feto-placental development? and 3) do
fetal and maternal genomes interact at the level of the placenta
to modify resource allocation during late mouse pregnancy? To
achieve this, we established reciprocal crosses of wildtype (WT)
and α/+ mice bearing litters of mixed genotype.
Results
p110α deficiency affects feto-placental growth
To unravel the role of p110α at the feto-maternal interface,
conceptus growth and placental phenotype were assessed on day
(D) 16 and D19 of pregnancy in WT and α/+ dams that had
been mated with α/+ and WTmales, respectively. Both crosses,
therefore, generated two fetal genotypes within a litter (i.e. WTs
Signiﬁcance
During pregnancy, nutrients are required for fetal growth and
for the mother to maintain the pregnancy. The placenta is
central to this tug-of-war over nutrients as it is responsible for
materno-fetal resource allocation. Failure to allocate resources
appropriately can lead to pregnancy complications and abnor-
mal fetal development with long-term health consequences
for both mother and baby. Here we use manipulation of a
growth-regulatory protein, p110α, in mice to compare the
importance of the maternal environment and genotype, with
fetal genotype, in determining placental resource allocation.
This study shows that the placenta ﬁne-tunes the supply of
maternal resources to the fetus via p110α in accordance with
both the fetal drive for growth, and the maternal ability to
supply the required nutrients.











































































































































Fig. 1. Feto-placental growth in response to p110α deﬁciency. Placental
(A, B) and fetal weights (C, D) on D16 (A, C) and D19 (B, D) of pregnancy.
Data from crosses where the mother is WT (circle symbols) and α/+ (triangle
symbols) with mean denoted as a horizontal line with SEM. Number of
fetuses in parentheses. *Signiﬁcantly different to WT littermates (P<0.05,
pairwise comparison). †Signiﬁcantly different to WT dams (P<0.05, pairwise
comparison).
Fig. 2. The effect of p110α deﬁciency on maternal body weight (A), hepatic
weight (B) and circulating metabolic indicators (C). Mean±SEM values from
age-matched non-fasted WT and α/+ littermates. *Signiﬁcantly different
to WT dams (P<0.05, t test comparison).Numbers of mice used for body
composition and blood glucose were 7-11 and for plasma metabolites and
hormones were 5-8 samples per genotype, per age.
and heterozygous p110α mutants, α/+; Fig. S1). This breeding
strategy allows assessment of the effects of the p110α mutation
in the feto-placental unit (13), compared to WT littermates (re-
ferred to as fetal genotype and statistically as PFet) as well effects
of the p110α mutation in the mother, compared to WT dams
(PMat). Effects of both maternal and fetal genotypes are referred
throughout as fetal and maternal interaction (PFet*Mat).
There was no significant difference in the litter size of WT
and α/+ dams at either D16 or D19 (mean±SEM: D16, 6.5±0.3
and 6.7±0.4; D19, 6.3±0.4 vs 6.2±0.3, respectively) or in the
Fig. 3. Placental morphology in response to p110α deﬁciency. Placental
structure (A, B), labyrinthine composition (C, D) and substrate exchange
characteristics (E, F) onD16 (A, C, E) and 19 (B, D, F) of pregnancy. Mean±SEM
values for >5 litters per maternal genotype per gestational age. From each
litter, 1-2 placentas per genotype were analysed for gross structure. Across
4-5 litters, a representative placenta per genotype, per cross was taken for
labyrinthine zone analysis. *Signiﬁcantly different toWT littermates (P<0.05,
pairwise comparisons). †Signiﬁcantly different to WT dams (P<0.05, pairwise
comparisons).
Fig. 4. Placental nutrient transfer in response to p110α deﬁciency.Materno-
fetal transfer of MeG and MeAIB on D16 (A and C) and 19 (B and D) of
pregnancy expressed relative to the exchange surface area (A, B) and/or
per gram of fetus (C, D). Mean±SEM for 8 and 10 litters on D16 (n=23-36
per fetal genotype, per cross) and 5 and 5 litters on D19 (n=15-19), for WT
and α/+ dams, respectively. *Signiﬁcantly different toWT littermates (P<0.05,
pairwise comparisons). †Signiﬁcantly different to WT dams (P<0.05, pairwise
comparisons).SA, exchange surface area.
ratio of WT to α/+ fetuses per litter (mean±SEM: 0.49±0.03
versus 0.51±0.03 for litters in WT and α/+ dams at both days of
pregnancy). α/+ placentas and fetuses were significantly lighter
than WT at both ages (Fig. 1; PFet<0.01). The average growth
restriction of α/+ placentas across maternal genotypes was 9%
and 12%ofWT, at D16 andD19, respectively, with corresponding
fetal growth restriction of 19% and 11% of WT. Consequently,
placental efficiency (measured as weight ratio of fetus to pla-
centa) in α/+ fetuses was reduced at D16 but not D19 (Fig. S2;
PFet<0.001). Both placental weight and efficiency, but not fetal
weight, were significantly influenced bymaternal genotype atD19











































































































































Fig. 5. Summary illustration showing the effects of maternal genotype
(green text boxes), fetal genotype (purple text boxes) and their interplay
(pink text boxes) in determining placental phenotype at D19 of pregnancy.
‡transfer per unit SA. AA, amino acid; BT, barrier thickness; FC, fetal capillar-
ies; Jz, junctional zone; Lz, labyrinthine zone; SA, surface area for exchange;
Troph, trophoblast.
α/+ dams were heavier (+15%, Fig. 1B; PMat<0.05) and less
efficient relative to WT dams (Fig. S2; PMat<0.05), irrespective
of fetal genotype. These findings reveal for the first time that
fetal p110α deficiency causes placental growth restriction and that
maternal p110α genotype affects placental weight and efficiency
but not fetal weight, particularly at D19. The latter suggest a role
for maternal genotype in programming placental phenotype.
p110α deficiency alters female endocrine and metabolic profile
We therefore determined whether p110α genotype affected
the metabolic and endocrine profile of non-pregnant (NP) and
pregnant female mice. Age-matched α/+ NP females were 14%
lighter than WT (Fig. 2A), in line with previous observations
of postnatal growth for these mice (13). Consistent with lower
starting D1 weights (mean±SEM: 21.8±0.3g and 19.4±0.3g for
WT and α/+ dams, P<0.05, respectively), age-matched, time-
mated α/+ females were 10% lighter than their WT counter-
parts at D16 and D19, in whole body and hysterectomised weight
(Fig. 2A). Gravid uterus mass, however, was similar in the two
maternal genotypes (Fig. 2A). Absolute liver weight was 20-25%
less in α/+ than WT females. In NP females, this reduction was
in line with the reduced body weight, whereas during pregnancy,
the liver accounted for a smaller proportion of hysterectomised
weight in α/+ thanWT dams (Fig. 2B). At D16, α/+ females were
hyperinsulinemic, with concentrations 5.3-fold higher than WT
values (Fig. 2C, trends only observed for NP and D19 pregnant
dams). Compared to WTs, NP α/+ females were hypoglycaemic
(glucose concentration -14%), however, during pregnancy they
were normoglycemic, suggesting insulin resistance of theα/+ dam
particularly at D16 (Fig. 2C). Whilst there was no difference in
plasma leptin with genotype prior to pregnancy, D16 α/+ preg-
nant females were hyperleptinemic (+80%), with concentrations
returning to WT values by D19 (Fig. 2C). Plasma concentrations
of cholesterol in NP α/+ females were 19% lower than WT but
did not differ between genotypes during pregnancy (Fig. 2C).
α/+ females had lower plasma triglycerides specifically on D19
(-22%) although free fatty acid concentrations were unaffected
by genotype either before or during pregnancy (Fig. 2C). Thus,
p110α deficiency altered body composition and the endocrine and
metabolic state in both NP and pregnant states but with more
pronounced effects during pregnancy. These metabolic changes
are likely to impact on placental phenotype which we interrogated
next.
p110α deficiency impairs the formation of the placenta
We assessed whether changes in placental growth with fetal
and maternal p110α genotype were accompanied by morpholog-
ical alterations using stereology. With respect to fetal genotype,
the placental exchange labyrinthine zone (Lz) was 18% smaller in
α/+ thanWT littermates (Fig. 3A-B; PFet<0.05) and related to re-
ductions in the fetal capillary volume (-41% and -47%), exchange
surface area (-22% and -27%) and in diffusion capacity (-47 and -
36%), at D16 andD19, respectively (Fig. 3C-F; PFet<0.01). These
changes were accompanied by a 20% thicker barrier between
the fetal and maternal blood spaces and a 25% reduction in
fetal capillary length, at both ages (Fig. 3E-F and Fig. S3). α/+
placentas had 30% less maternal blood space volume at D16 and
12% less trophoblast at D19 compared to WT littermates (Fig.
3C-D; PFet<0.05).
Maternal genotype affected placental Lz morphology at both
ages (PMat<0.04), but with opposite effects at the two ages. At
D16 in α/+ dams, the volumes of the placental Lz and trophoblast
were reduced (-9% and -17%, respectively), fetal capillaries were
14% shorter and exchange barrier was 11% thinner compared to
WT dams (Fig. 3A and E and Fig. S3A). At D19 in α/+ dams,
the volume of the placental endocrine junctional zone (Jz) was
46% greater, the fetal capillaries were 18% larger in diameter,
the diffusing capacity 52% greater and the exchange surface 34%
greater (Fig. 3B and F and Fig. S3B).
There were significant interactions between maternal and
fetal genomes in determining fetal capillary length and diameter
on D16 (PFet*Mat<0.03). Placental capillaries were significantly
shorter (-29%) in WT fetuses of α/+ dams specifically, whilst
diameter was reduced (-18%) in α/+ fetuses of α/+ dams only
(Fig. S3A). There were also interactions between fetal and ma-
ternal genotypes at the level of placental nutrient storage at
D16. There was no difference in glycogen content between WT
and α/+ placentas in WT dams (mean±SEM: 9.7±0.4mg/g vs
9.9±0.7mg/g) whereas, in α/+ dams, glycogen content was re-
duced by 38% in α/+ placentas compared to their WT littermates
(mean±SEM: 8.7±0.7mg/g vs 5.7±0.4mg/g for WT and α/+, re-
spectively, P<0.001). Collectively, these data indicate that fetal
and maternal genotypes interact to modify the morphology and
composition of the placenta.
p110α deficiency affects placental nutrient transport
To assess whether placental transport function was altered
by lack of p110α in either the fetus and/or mother, we deter-
mined the in vivo uni-directional, materno-fetal transfer of the
non-metabolisable analogues of glucose and a neutral amino
acid using 3H-methyl D-Glucose (MeG) and14C-methyl amino-
isobutyric acid (MeAIB), respectively at D16 and at D19. Since
themutant placentas were smaller relative to theirWT littermates
at these ages, we measured absolute accumulation of radioiso-
topes by the fetus and also expressed fetal counts relative to
estimated surface area for transport and/or to fetal weight, which
provide indices of the placental capacity for nutrient transfer and
fetal growth relative to supply.
Placental transfer of both MeG and MeAIB relative to esti-
mated surface area shows that α/+ mutant placentas transferred
more of both solutes compared to WT at both gestational ages
(+56% and+107% forMeG and+30 and +122% forMeAIB at
D16 and D19, respectively, Fig. 4A-B; PFet <0.001). This suggests
the α/+ placenta transfers the solutes with increased efficiency
in compensation for the reduced surface area. In agreement with
these findings, mutant fetuses received either normal or increased
amount of solutes for their size (Fig. 4C-D; PFet<0.004), even
though the absolute amount of MeG and MeAIB solute received
by the α/+ fetus is reduced atD16 (Fig. S4). The increase in solute
transfer per surface area is most evident at D19 (Fig. 4B) and is
related to less severe growth restriction of α/+ fetuses than atD16











































































































































Maternal genotype also exerted a significant effect on placen-
tal MeG transfer (Fig. 4; PMat<0.05). Overall placental transfer
of this solute estimated per unit surface area was reduced in α/+
compared to WT dams at both ages (63% average of WT, Fig.
4A-B), with30% less fetal accumulation of MeG irrespective of
fetal genotype at D16 (PMat<0.05; Fig. 4C and Fig. S4). At D19,
reduced fetal accumulation of MeG was only seen in WT fetuses
of α/+ dams (-55%, Fig. 4D; PFet*Mat<0.01). There were also
fetal-maternal genotype interactions modulating fetal MeAIB
accumulation at both ages (PFet*Mat<0.05, Fig. 4C and D). In
particular, the WT fetus accumulated more MeAIB in α/+ dams
on D16, when compared to WT (Fig. 4C). Furthermore, in α/+
but notWTdams,α/+ fetuses accumulated lessMeAIB than their
WT littermate onD16 (Fig. 4C). Thus, placental transfer capacity
is modified by both fetal and maternal genotypes, however the
specific nature of the changes depends on gestational age and the
nutrient.
p110α deficiency alters placental expression of nutrient trans-
porters and lineage genes
Finally, we sought to identify the molecular mechanisms al-
tering placental MeG and MeAIB transport in α/+ fetuses in
WT and α/+ dams. We assessed placental expression of genes
encoding the glucose (SLC2A; Slc2a1 and Slc2a3) and System A
amino acid (SLC38A; Slc38a1, Slc38a2 and Slc38a4) transporter
proteins. We also measured expression of placental cell lineage
genes, which in some cases have been implicated in regulating
materno-fetal nutrient allocation (20-22).
Maternal genotype had the strongest effect on placental
expression of the transporter and cell lineage genes, although
fetal genotype determined the specific nature of the effect (Table
S1). In particular, at D16, the placental expression of Slc38a1
and the giant cell gene Hand1 were reduced in α/+ dams by
40% and35%, respectively, compared toWT dams (Table S1;
PMat<0.01). In α/+ dams, Slc38a1 continued to be expressed at
lower levels at D19, with expression of Slc2a1 and Slc38a2 trans-
porter genes also now reduced by18% (PMat<0.001). There was
no effect of fetal genotype on placental expression of any of the
nutrient transporters at either age studied (Table S1).
At D19, the fetal endothelium Mest gene, Jz spongiotro-
phoblast genes Prl3b1, Prl8a8, Lz sinusoidal giant cell gene Ctsq
and syncytial trophoblast genes Gcm1 and Syna, were also lower
in expression (ranging from -15% to -60%) in litters carried by
α/+ compared to WT dams (Table S1). Mest and Prl3b1 expres-
sion were also affected by fetal genotype at D19, with lower
and higher expression, respectively in α/+ than WT placentas (-
12% and +24%, respectively, PFet<0.05, Table S1). There was
also fetal-maternal genotype interactions in regulating Syna gene
expression at both ages (PFet*Mat<0.05, Table S1). Thus, fetal and
maternal genomes interact to modulate placental expression of
several cell lineage genes, particularly at D19 of pregnancy.
Discussion
This study shows for the first time that: (i) signalling via PI3K-
p110α regulates the formation and function of the mouse pla-
centa, (ii) placental phenotype is influenced by maternal p110α
genotype and (iii) there is an interplay between fetal andmaternal
genotypes in determining specific placental phenotypes. Using
genetic manipulation of p110α (13), this study demonstrates that
development of the placental exchange region was impaired by
D16 of pregnancy in association with reduced growth of α/+
fetuses. However, despite its compromised morphology, the α/+
placenta adapted functionally to increase the supply of maternal
nutrients to the fetus, an effect that was more pronounced near
term. The specific nature of these changes however, depended on
whether the mother was WT or mutant, which probably relates,
in part, to the altered endocrine and metabolic profile of α/+
dams. Because of these maternal genotype-driven adaptations
in placental phenotype, fetal growth was unaffected by maternal
genotype. Thus, by acting on placental phenotype, signalling via
p110α kinase is critical in integrating intrinsic and extrinsic signals
governing the balance of materno-fetal resource allocation to
fetal growth.
(i) Signalling via PI3K-p110α regulates placental formation
We found that the α/+ placenta was lighter at both D16
and D19 of pregnancy and there were defects in the formation
of the Lz, irrespective of maternal genotype. At both ages, Lz
vascularization was impaired; the fetal capillaries were reduced
in volume and shorter in length in the α/+ placentas. Reduced
vascularisation of the α/+ placenta is consistent with previous
work showing impaired developmental angiogenesis and vascular
patterning in these mutant fetuses (19).
At D16, but not D19, the volume of Lz maternal blood spaces
was also decreased in α/+ placenta. This may reflect delayed
trophoblast-induced dilation of the uterine spiral arteries, which
normally occurs by D14.5 of pregnancy (23) as PI3K signalling
also regulates the differentiation and invasive properties of tro-
phoblast (24). At both ages, the trophoblast interhemal mem-
brane was thicker and the surface area for exchange was reduced
in the α/+ placenta, which resulted in a decreasd theoretical
diffusing capacity. Changes in Lz morphology of the α/+ mutants
were similar to those reported previously for mice deficient in
Igf2, as well as the PI3K effector protein, protein kinase b (Akt1)
(25, 26). Together, these data suggest that p110α is a main me-
diator of IGF2 actions, operating primarily via AKT1 to attain
normal placental weight and Lz structure in mice.
As expected, the changes in Lz morphology of the α/+ pla-
centas impaired the normal capacity to deliver nutrients from
mother to fetus; the absolute amount of MeG (significant in WT
dams) and MeAIB solute received by the α/+ fetus was reduced
at D16, compared to WT littermates. However, estimating the
placental transfer of these solutes per unit exchange surface area
showed greater transport for α/+ fetuses at both ages, suggesting
compensatory adaptive mechanisms of both facilitated and active
transport in the α/+ placenta. This upregulation of placental
transport achieved greater amounts of solute per gram fetal mass
in α/+ mutants compared to their WT littermates at D19 and
was associated with an improved fetal growth trajectory of α/+
compared to WT. Alterations in nutrient transport capacity were
however, unrelated to expression of Slc2a and Slc38a glucose and
amino acid transporter genes in the α/+ placenta at either age.
Adaptive upregulation of placental transport function has been
seen when the fetal demand for maternal resources exceeds the
supply capacity of the placenta following deletion of the Slc2a3
glucose transporter gene, in naturally small placentas within lit-
ters and when placental growth is impaired by a deficiency in the
Lz-specific Igf2 transcript or the 11-β hydroxysteroid dehydroge-
nase gene (27-31). Moreover, System A amino acid transporter
activity is adaptively up-regulated in the small human placenta of
infants at the lower end of the normal birthweight range (32), but
is diminished in pathological pregnancies with severe fetal growth
restriction (33, 34). Further work is required to determine the
mechanism by which the α/+ placenta adapts, largely indepen-
dent of maternal genotype. Further work should also identify the
whether fetal sex influences the observed alterations in placental
phenotype with fetal genotype, and their possible interaction with
the maternal environment (35).
(ii) Placental phenotype is modified by maternal p110α genotype
Placental transport for both WT and α/+ fetuses were ad-
ditionally influenced by the phenotype of the α/+ dam. α/+
female mice were lighter and exhibited an altered endocrine and
metabolic profile prior to pregnancy. However, some of these
changes were exacerbated (fractional liver weight, hyperinsu-
linemia, hyperleptinemia and hypotriglyceridemia) and others











































































































































AtD16 of pregnancy, Lz volume and its volume of trophoblast
were less and fetal capillaries shorter particularly for WT pla-
centas, in α/+ dams, even though absolute placental weight was
not altered by maternal genotype at this age. Reduced placental
vascularisation has been observed in embryos transferred to re-
cipients of a smaller breed (8, 36) and, thus, the current findings
suggest that the smaller-sized α/+ dam may be attempting to
constrain fetal growth via actions on the placental supply capacity.
Indeed, the placental ability to transport MeG per gram fetus was
less for bothWT and α/+ fetuses in α/+ dams atD16 compared to
WT. These observations are also consistent with reduced placen-
tal glucose transport capacity in cows of small maternal size (9),
sheep of young maternal age (37) as well as in mouse pregnancies
where fetal demand for growth exceeds the maternal ability to
supply nutrients via the placenta (38). Reduced MeG transfer
may also be related to elevated insulin concentrations in α/+
dams, as chronic exposure to maternal hyperinsulinemia reduces
placental uptake and fetal supply of glucose (39) and diminished
placental glucose transfer occurs in late gestation in association
with hyperinsulinemia and other changes in maternal-nutrient
partitioning in pregnant mice treated with glucocorticoids (17).
In contrast to MeG transport, there was no independent effect
of maternal genotype on MeAIB transfer. This occurred despite
reduced placental expression of the amino acid transporter gene,
Slc38a1 in litters of α/+ dams (also at D19 along with decreased
Slc38a2). Similar disparity between Slc38a gene expression and
transport of MeAIB in vivo, has been observed in placentas in
which growth regulatory genes (15) or the maternal environment
have been affected in rodents (3-7). These findings suggest that
there are temporal differences between the expression, trans-
lation and membrane trafficking of amino acid transporters in
the placenta, and that measuring placental expression of Slc38a
genes provides little information with respect to actual transport
function in vivo. Further work should investigate the contribution
of other transporters that are responsible for facilitating amino
acid accumulation, exchange and efflux in the placenta (40). In
α/+ dams, the placental barrier to exchange was however, thinner
at D16 irrespective of fetal genotype. This structural alteration
would have optimised passive diffusion of molecules, such as oxy-
gen, which could be beneficial for fetal growth, particularly given
the compromised glucose transfer and maternal environment in
α/+ dams.
There were also changes in placental morphology specific
to α/+ dams on D19. Placentas were heavier and the exchange
surface area larger for both fetal genotypes in α/+, compared
to WT dams. Expression of the Gcm1 gene, which is involved
in early patterning of the Lz vasculature was reduced and fetal
capillaries were larger in calibre and showed reduced Mest ex-
pression, irrespective of fetal genotype, in placentas of α/+ dams,
which taken together may indicate a more advanced Lz vascular
phenotype (22, 23). Increased placental growth and maturation
of the exchange area would have enhanced the placental capacity
to supply nutrients and oxygen to the fetus and suggest that
the placenta adapts morphologically in response to the altered
maternal environment induced by maternal p110α deficiency.
Beneficial changes in placental morphology have also been ob-
served in response to suboptimal maternal environments, includ-
ing poor nutrition, hypoxia and glucocorticoid over-exposure in
many species (3-7).
(iii) Interplay between fetal and maternal genotypes in determin-
ing specific placental phenotypes
Fetal and maternal genomes also interacted at the level of
placental nutrient storage and endocrine capacity. In α/+, but
not WT dams, glycogen storage in the α/+ placenta was dimin-
ished on D16. Placental glycogen content is reduced in dams
fed diets high in sugar and fat and in dams carrying Igf2P0
null litters, both conditions in which there are signs of maternal
insulin resistance and altered placental PI3K signalling (15, 16).
α/+ dams were normoglycemic despite their hyperinsulinemia
at D16, indicative of maternal insulin resistance in this mutant
too. However, in contrast to the α/+ placenta, glycogen content
of the WT placenta was not affected by maternal genotype,
which suggests that signalling via p110α in the mouse placenta
is required to maintain placental glycogen under conditions of
maternal insulin resistance. Future investigations should deter-
mine whether the differentiation and/or lysis of glycogen cells
in the Jz (41), is altered in response to fetal and maternal
p110α deficiency especially since Jz volume was greater for both
fetal genotypes in mutant dams at D19. Maternal genotype also
affected the expression of different cell lineage genes in the
placental Lz (Syna, Mest, Gcm1 and Ctsq) and the Jz (Prl8a8
and Prl3b1). In some instances, fetal genotype determined the
extent of the effect. For instance, spongiotrophophoblast Prl8a8
expression was significantly decreased in α/+, but not WT fe-
tuses in mutant dams at D19. Moreover, depending on maternal
genotype, the α/+ placenta exhibited increased expression of the
Prl3b1/chorionic somatomammotropin-2 gene, compared to WT
littermates at D19. Insulin secretion and β-cell proliferation are
increased by placental production of the prolactin/chorionic so-
matomammotropin family of hormones (PRL/CSH) (42). Future
work should determine the inter-relationship between changes in
the endocrine Jz and the metabolic state of the α/+ dams.
Due to overall differences in placental weight, structure and
functional capacity, the outcome for fetal growth was the same
in α/+ and WT dams (i.e. there was no interaction of fetal and
maternal genomes on fetal weight). These findings suggest that
the placenta acts as a ‘buffer’ to fine-tune the supply of maternal
resources to the fetus in accordance with both the genetically-
determined fetal drive for growth, and the maternal ability to
supply the nutrients required for fetal growth. However, the
adaptive signals modifying placental transport capacity in α/+
mutants in late pregnancy remain to be identified, although they
are likely to originate from both the mother and the growth
restricted conceptus (Fig. 5). The relative contribution of the
fetus and placenta to placental phenotype and adaptive responses
could not be determined as both the fetus and placenta carry the
mutation in α/+ conceptuses. Future work could use cell-selective
manipulation of the p110α gene to examine the specific contribu-
tion of these tissues in the regulation of placental phenotype.
In the present study, the fetal weight to placental weight ratio,
which is often used as a proxy measure of placental efficiency
(3), did not always track with nutrient transfer estimated per unit
placental surface area. Numerous factors determine the ability
of the placenta to support fetal nutrient provision and growth,
beyond simply its wet weight; including surface area, vascularity
and activity of nutrient transporters (43). This work therefore,
highlights that caution is warranted when interpreting changes in
the fetal weight to placental weight ratio, particularly if there is no
information on the morphological or functional characteristics of
the placenta.
In summary, our data show that the WT and α/+ placenta
adopt different strategies at the level of nutrient supply capacity,
to cope with the altered metabolic state of the α/+ dam and,
in a broader sense, emphasise the interplay between maternal
and fetal genomes in determining the amount of materno-fetal
resource allocation (Fig. 5). These findings are important in
the context of human pregnancy as dysregulated expression of
both up and down-stream components of the PI3K pathway have
been reported in human placenta associated with abnormal fetal
growth (44-50). Furthermore, our study highlights the usefulness
of the PI3K α/+ mouse as a tool for investigating the role and
mechanisms of maternal-fetal genomic interactions in determin-













































































































































Mice were housed in the University of Cambridge Animal Facility abiding
by the UK Home Ofﬁce Animals (Scientiﬁc Procedures) Act 1986 and local
ethics committee. Virgin 10 week old C57BL/6 WT and α/+ female mice were
mated to α/+ and WT males, respectively. α/+ mice were backcrossed to
C57BL/6 for >8 generations. On D16 or 19 of pregnancy, dams were anaes-
thetised (fentanyl-ﬂuanisone:midazolam in sterile water at 1:1:2, Jansen
Animal Health) and underwent a placental nutrient transfer assay or were
used for maternal blood collection by cardiac puncture and liver retrieved
following cervical dislocation. Virgin 8-10 week old WT and α/+ female
mice (littermates) were anaesthetised, blood collected and liver weighed
as for pregnant mice. The α/+ mice were previously generated as described
in (13) and genotyped using primers 5’-TTCAAGCACTGTTTCAGCT-3’ and 5’-
TTATGTTCTTGCTCAAGTCCTA-3’. Blood glucose and plasma concentrations
of leptin, insulin, triglycerides, cholesterol and free fatty acids were deter-
mined as reported (51). Materno-fetal clearance of MeAIB (NEN NEC-671;
speciﬁc activity 1.86GBq/mmol, Perkin Elmer, Massachusetts, USA) and MeG
(NEN NEC-377; speciﬁc activity 2.1GBq/mmol) were measured two minutes
after maternal tracer injection as described (52). Entire litters of placentas
were collected for morphological analyses using the Computer Assisted
Stereological Toolbox program as previously described (16), or snap frozen
for quantiﬁcation of gene expression by qPCR (Table S2), or tissue glycogen
content using amyloglucosidase as reported (51). Data were analysed using
SPSS 21 using t test (effect of genotype on maternal body composition)
or 2-way ANOVA (effect of maternal and fetus genotype) with pairwise
comparisons. Data from individual litters (fetal and placental weights and
transport) were analysed using a 2-factor generalized linear mixed-model
(maternal and fetus genotypes as factors), with litter identiﬁed as a random
effect, followed by sequential pairwise comparisons to assess the effect of
maternal and/or fetal genotype. Data were signiﬁcant when P<0.05.
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